MedPath

Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease

Completed
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
Other: Pulmonary rehabilitation
Registration Number
NCT03244137
Lead Sponsor
ADIR Association
Brief Summary

Chronic obstructive pulmonary disease is a leading cause of mortality worldwide.

It is a systemic disease which includes pulmonary, cardiac, muscular, digestive and cognitive impairments.

Pulmonary rehabilitation is a symptomatic treatment to reduce dyspnea and functional incapacity. However, it effects on cognitive dysfunction are not well known.

The aim of this study is to assess the effects of a comprehensive pulmonary rehabilitation program on cognitive dysfunction in patients with severe to very severe chronic obstructive pulmonary disease using the Montreal Cognitive Assessment tool.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
56
Inclusion Criteria
  • Age > 18years;
  • Chronic obstructive pulmonary disease stade III to IV;
  • Referred for pulmonary rehabilitation.

Non Inclusion Criteria:

  • Pregnancy or likely to be;
  • History of psychiatric, neuro-vascular, cognitive disease or cranial trauma;
  • Active alcoholism;
  • Guardianship;
  • Hospitalisation for acute exacerbation of chronic obstructive pulmonary disease in the previous 4 weeks;
Exclusion Criteria
  • Interruption of the pulmonary rehabilitation program > 15 days;
  • Disruption of the training before the 18th session;
  • Less than 18 sessions in four month.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Pulmonary rehabilitationPulmonary rehabilitationThe whole population will benefit from a comprehensive pulmonary rehabilitation program, including aerobic training, superior and inferior limb strength training, self-management and add-on to pulmonary rehabilitation as needed (i.e : electrical muscle stimulation, inspiratory muscle training, non-invasive ventilation, high flow nasal canula).
Primary Outcome Measures
NameTimeMethod
Baseline cognitive functionCognitive function is assessed at the beginning of the rehabilitation program : day 0

Cognitive function is assessed with the Montreal Cognitive Assessement tool

Cognitive function : follow upCognitive function is assessed 3 month after rehabilitation : day 150

Cognitive function is assessed with the Montreal Cognitive Assessement tool

Cognitive function after pulmonary rehabilitationCognitive function is assessed at the end of the rehabilitation program : day 60

Cognitive function is assessed with the Montreal Cognitive Assessement tool

Change in cognitive function from baseline to the end of pulmonary rehabilitationChange in cognitive function from baseline to the end of pulmonary rehabilitation is assessed with end of pulmonary rehabilitation minus baseline values (day 60 - day 0)

Cognitive function is assessed with the Montreal Cognitive Assessement tool

Change in cognitive function from the end of pulmonary rehabilitation to 3 month of follow upChange in cognitive function from the end of pulmonary rehabilitation to 3 month of follow up is assessed with the 3 month of follow minus the end of pulmonary rehabilitation values (day 150 - day 60)

Cognitive function is assessed with the Montreal Cognitive Assessement tool

Secondary Outcome Measures
NameTimeMethod
Functional capacity (six-minute stepper test) : baselineFunctional capacity is assessed at the beginning of the rehabilitation program : day 0

Functional capacity is assessed with the six-minute stepper test

Functional capacity (six-minute stepper test) : end of pulmonary rehabilitationFunctional capacity is assessed at the end of the rehabilitation program : day 60

Functional capacity is assessed with the six-minute stepper test

Anxiety and depression : end of pulmonary rehabilitationAnxiety and depression are assessed at the end of the rehabilitation program : day 60

Anxiety and depression are assessed with the Hospital Anxiety and Depression scale (HAD).

Quality of life : end of pulmonary rehabilitationQuality of life is assessed at the end of the rehabilitation program : day 60

Quality of life is assessed using the Saint Georges Respiratory Questionnaire

Quality of life : follow-upQuality of life is assessed 3 month after the end of the rehabilitation program : day 150

Quality of life is assessed using the Saint Georges Respiratory Questionnaire

Anxiety and depression : baselineAnxiety and depression are assessed at the beginning of the rehabilitation program : day 0

Anxiety and depression are assessed with the Hospital Anxiety and Depression scale (HAD).

Anxiety and depression : follow upAnxiety and depression are assesses 3 month after the end of pulmonary rehabilitation program : day 150

Anxiety and depression are assessed with the Hospital Anxiety and Depression scale (HAD).

Quality of life : baselineQuality of life is assessed at the beginning of the rehabilitation program : day 0

Quality of life is assessed using the Saint Georges Respiratory Questionnaire

Functional capacity (six-minute walk test) : baselineFunctional capacity is assessed at the beginning of the rehabilitation program : day 0

Functional capacity is assessed with the six-minute walk test

Relation between the cognitive function and the respiratory function (forced expiratory volume in 1 second)The relation is assessed between baseline demographic data at day 0

Cognitive function is assessed with the Montreal Cognitive Assessement tool and respiratory function is assessed with spirometric evaluation

AdherenceAdherence is assessed at the end of the rehabilitation program : day 60

Adherence to the pulmonary rehabilitation program is assessed by the following equation : number of session performed divided by the number of scheduled sessions

Trial Locations

Locations (2)

Bonnevie

🇫🇷

Bois-Guillaume, France

Médrinal

🇫🇷

Le Havre, France

Bonnevie
🇫🇷Bois-Guillaume, France
© Copyright 2025. All Rights Reserved by MedPath